CELCUITY INC. Adjustments to Additional Paid in Capital, Warrant Issued
CELCUITY INC. (CELC) reported Adjustments to Additional Paid in Capital, Warrant Issued of $1.23 million for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-26.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued · last filed 2026-03-26
- CELCUITY INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2024-06-30 was $1.23M.
- CELCUITY INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2021-06-30 was $289.84K.
- CELCUITY INC. adjustments to additional paid in capital, warrant issued for fiscal 2024 was $1.23M.
- CELCUITY INC. adjustments to additional paid in capital, warrant issued for fiscal 2021 was $289.84K.
| Period end | Adjustments to Additional Paid in Capital, Warrant Issued 3 month | Adjustments to Additional Paid in Capital, Warrant Issued 3 month as first filed | Adjustments to Additional Paid in Capital, Warrant Issued 12 month | Adjustments to Additional Paid in Capital, Warrant Issued 12 month as first filed |
|---|---|---|---|---|
| 2024-12-31 | $1.23M 10-K · filed 2026-03-26 | $1.23M 10-K · filed 2025-03-31 | ||
| 2024-06-30 | $1.23M 10-Q · filed 2025-11-13 | $1.23M 10-Q · filed 2024-08-14 | ||
| 2021-12-31 | $289.84K 10-K · filed 2023-03-23 | |||
| 2021-06-30 | $289.84K 10-Q · filed 2022-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |